Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|October 30, 2024
Synthesis and biological evaluation of 4,7,9-trisubstituted benzoxazepines as antileishmanial agentsTara Man Kadayat, Stefan Kwiatkowski, Diana Ortiz, et al.
Journal of Medicinal Chemistry|May 4, 2021
Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2MHo Shin Kim, Jared T Hammill, Daniel C Scott, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
The SAR analysis of TRPV1 agonists with the α-methylated B-regionYongsung Cho, Myeong Seop Kim, Ho Shin Kim, et al.
ACS Sensors|July 24, 2018
Fluorescence Blinking as an Output Signal for BiosensingBrandon Roark, Jenna A Tan, Anna Ivanina, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2014
α-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonistsHo Shin Kim, Mi-Kyoung Jin, Sang-Uk Kang, et al.
Journal of Medicinal Chemistry|March 17, 2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin NeddylationJared T Hammill, Deepak Bhasin, Daniel C Scott, et al.
Journal of Medicinal Chemistry|November 9, 2019
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical AnalgesicJihyae Ann, Ho Shin Kim, Shivaji A Thorat, et al.
European Journal of Medicinal Chemistry|May 21, 2013
2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-regionShivaji A Thorat, Dong Wook Kang, HyungChul Ryu, et al.
Journal of Medicinal Chemistry|May 22, 2023
Optimization of Orally Bioavailable Antileishmanial 2,4,5-Trisubstituted BenzamidesHo Shin Kim, Diana Ortiz, Tara Man Kadayat, et al.
Pageof 4